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A variety of extended-spectrum β-lactamase–producing 
Escherichia coli isolates, with a high rate of cefotaximase-
15 resistance, were identiﬁ  ed in seagull feces from Porto, 
Portugal, beaches. Beaches may therefore present a risk to 
public health because of the potential pathogen-spreading 
capacity of migratory birds.
T
he Porto coastline in Portugal, including downtown 
Porto, has a large seagull population (Larus fuscus, 
the lesser black-backed gull, and L. cachinnans, the yel-
low-legged gull). Seagulls have been reported as a pos-
sible reservoir for multidrug-resistant bacteria (1). During 
the past decade, extended-spectrum β-lactamases (ESBL) 
with growing epidemiologic importance, the cefotaximase 
(CTX-M) enzymes, have been reported worldwide in En-
terobacteriaceae from humans (2); they are found mostly 
in Escherichia coli. Reasons for the emergence of CTX-M 
enzymes in human isolates remain unknown. In addition, 
CTX-M–positive E. coli have been identiﬁ  ed in poultry (3), 
other farm animals (4), and wild animals (birds of prey, 
foxes [5]). E. coli strains can be classiﬁ  ed into 4 phylo-
genetic groups (A, B1, B2, and D). The virulent extraint-
estinal isolates belong mostly to group B2 and, to a lesser 
extent, group D, whereas most commensal strains belong to 
groups A and B1. The objective of the study was to evalu-
ate the spread and types of ESBL-positive E. coli in feces 
recovered from wild birds on the beaches of Porto.
The Study
During December 2007 through April 2008, wild 
seagull (L. fuscus,  L. cachinnans) feces were collected 
from the Matosinhos and Leça da Palmeira beaches (Porto, 
Portugal) (20 samples every 2 weeks) using a sterile spat-
ula. Care was taken during sampling to avoid collection of 
beach sediment. Samples were placed in sterile tubes and 
processed. Samples were precultured in buffered peptone 
water (Oxoid, Basingstoke, UK) at a dilution of 1/10 wt/vol 
and incubated at 37°C. Cultures were injected by streaking 
10 μL of the suspensions onto Tergitol BCIG agar (Biokar 
Diagnostics, Beauvais, France). Another suspension was 
made in buffered peptone water supplemented with cefo-
taxime (CTX) at 2 μg/mL and then streaked in a Tergi-
tol BCIG plate supplemented with CTX at 2 μg/mL. The 
plates were incubated at 37°C overnight. We identiﬁ  ed 
E. coli isolates by using the API20E system (bioMérieux, 
Balmes-les-Grottes, France).
Susceptibility testing was performed by disk diffusion 
assay (Sanoﬁ   -Diagnostic Pasteur, Marnes-la-Coquette, 
France), as previously described (3). MICs were deter-
mined by Etest (AB BIODISK; Solna, Sweden) on Muel-
ler-Hinton agar plates at 37°C (8). ESBL was detected with 
a synergy test using disks containing CTX, ceftazidime, 
and ticarcillin-clavulanic acid (6).
Clonal diversity was assessed by pulsed-ﬁ  eld gel elec-
trophoresis (PFGE) as described (3). Genomic DNA was 
extracted in situ by treatment with lysozyme (1 mg/mL; 
Sigma, Saint-Quentin Fallavier, France) and proteinase K 
(0.5 mg/mL; Sigma) and then restricted with endonuclease 
XbaI (GE Healthcare, Aulnay-sous-Bois, France). We sep-
arated resulting fragments by using 1% PFGE-grade aga-
rose gel (Bio-Rad, Hercules, CA, USA) in a CHEF-DR II 
System (Bio-Rad), with the following protocol: 6 volts/cm, 
4–12 s pulse time for 12 h, followed by 15–36 s pulse time 
for 12 h in 0.5% tris-borate-EDTA buffer at 14°C.
Detection of blaCTX-M genes was carried out by PCR 
(3). We sequenced the puriﬁ  ed PCR products on both 
strands by using an Applied Biosystems sequencer (ABI 
377; Foster City, CA, USA) and analyzed these se-
quences in the BLAST database (www.ncbi.nlm.nih.gov/
blast/Blast.cgi). Phylogenetic grouping of E. coli isolates 
was determined by PCR (7) for assignation of phyloge-
netic groups: group B2, chuA+, yjaA+; group D, chuA+, 
yjaA–; group B1, chuA–, TspE4C2+; and group A, chuA–, 
TspE4C2–. Analysis of plasmid content was performed 
for the blaCTX-M-like positive isolates by using the Kieser 
technique (3). The multilocus sequence typing (MLST) 
of E. coli isolates was determined by sequencing 7 es-
sential genes (adk, fumC, icd, purA, gyrB, recA, and mdh) 
as described (8), followed by an analysis on the E. coli 
MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli) except 
for mdh, icd, and recA as performed in another study (9).
We obtained 139 E. coli isolates, of which 45 (32%) 
displayed an ESBL phenotype. Forty-four (98%) of the 
45 ESBL producers carried a blaCTX-M gene; 1 isolate pos-
sessed a blaTEM-52 gene. PCR and sequencing identiﬁ  ed 
the CTX-M ESBL determinants as follows: 8 (18%) were 
CTX-M-1; 4 (9%), CTX-M-9; 17 (39%), CTX-M-15; and 
15 (34%), CTX-M-32.
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PGFE analysis showed a high diversity of genotypes: 
8 clones for 8 CTX-M-1–positive isolates, 4 clones for 4 
CTX-M-9–positive isolates, 13 clones for 17 CTX-M-15–
positive isolates, and 14 clones for 15 CTX-M-32–positive 
isolates (data not shown). A total of 37% of ESBL pro-
ducers belonged to virulent extraintestinal groups B2 and 
D. Of these isolates, 41% expressed CTX-M-15 and 47% 
expressed CTX-M-32.
MLST identiﬁ  ed 25 different types among the 45 E. 
coli isolates. The most commonly identiﬁ  ed  genotypes 
were ST1284 (4 isolates), ST131 (4), and ST224 (3). Iso-
lates belonging to ST453, ST86, ST205, ST359, ST165, 
ST69, ST1152, ST405, ST559, ST1163, ST10, ST58, 
ST156, ST155, ST10, ST297, ST43, ST58, and ST156 
were also identiﬁ  ed. Different genotypes carrying the same 
ESBL determinant were identiﬁ  ed; conversely, different 
ESBL determinants were found among the same genotype. 
In particular, isolates belonging to the ST131 genotype 
widely reported among human CTX-M-15–positive E. coli 
producers (9,10) harbored either blaCTX-M-32 (2 isolates), 
blaCTX-M-1 (1), or blaCTX-M-15 (1). Coresistances of the 45 ES-
BL-positive isolates were as follows: 90% were resistant 
to tetracycline; 60%, to trimethoprim/sulfamethoxazole; 
55%, to nalidixic acid; 50%, to ciproﬂ  oxacin; 23%, to gen-
tamicin; and 4%, to chloramphenicol.
Identiﬁ   cation of the phylogroups of the different 
CTX-M producers showed that most belonged to phylo-
group B1, and a notable number of isolates belonged to 
phylogroup D (Figure). In contrast, few isolates belonged 
to the highly virulent phylogroup B2. Whereas CTX-M-1 
producers mostly belonged to phylogroup B1, the CTX-
M-15 producers were well distributed among the 4 phy-
logroups (Figure). Notably, plasmid analysis identiﬁ  ed a 
sizable diversity of plasmid sizes, including E. coli isolates 
producing the same CTX-M type (data not shown).
Conclusions
CTX-M type β-lactamases are ESBLs of increasing 
prevalence (2). Infections with multidrug-resistant bacilli 
occur not only in hospitals but also in the community (11). 
Previous studies have reported multidrug-resistance in wild 
birds (12,13). Our study provides additional clues that wild 
seagulls are carriers of ESBL-producing E. coli, although 
at a lower rate than previously reported (1). In that study, 
ESBL determinants were TEM-52, CTX-M-1, CTX-M-
14a, and CTX-M-32 (1). Another study (focused on poul-
try) (3) reported that the main identiﬁ  ed CTX-M determi-
nants were of the CTX-M-1 group (CTX-M-1, CTX-M-15, 
CTX-M-32), as we also found.
We report that CTX-M-15 was the main CTX-M 
type identiﬁ  ed among birds residing mostly on beaches of 
downtown Porto, which agrees with CTX-M-15 being the 
most prevalent ESBL in E. coli in Porto-hospitalized pa-
tients (14). This observation differs from those of a study 
reporting mostly TEM-52 producers in wild animals in a 
reserve near Porto, where indirect contacts with humans are 
less likely (5). 
Previous studies have reported the association of E. 
coli isolates of groups B2 and D with extraintestinal infec-
tions (15). Our report shows that 37% of all ESBL isolates 
belong to B2 or D phylogroup, a higher rate than previ-
ously reported (27% of all ESBL) (1). This ﬁ  nding could be 
a matter of concern for human health. However, we showed 
that the ST131 type known to be frequently isolated in hu-
mans and frequently associated with CTX-M-15 produc-
tion was quite rare (9%). In addition, those ST131 strains 
were found to harbor diverse CTX-M determinants. In fact, 
the frequent identiﬁ  cation of CTX-M producers here was 
related neither to the dissemination of a single clone nor to 
that of a single plasmid.
Our report suggests that beaches may play a major role 
in dissemination of resistance determinants and may be a 
source of the CTX-M-15–related community-acquired in-
fections. Migratory birds, such as seagulls crossing an ex-
tensive portion of the European coastline between Portugal 
and Scandinavia, may be reservoirs for these emerging re-
sistance determinants. 
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Figure. Distribution of isolates positive for cefotaximase (CTX-M) 
by phylogenetics group. Vertical axis indicates the percentage for 
each CTX-M determinant.References
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